Sichuan Kelun-Biotech’s RMB220M Wealth Management Move

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced its subscription to wealth management products from Industrial Bank, with a total investment of RMB220 million. The transactions include two large-denomination negotiable certificates of deposit totaling RMB120 million and a structured deposit of RMB100 million, both offering an expected annualized return of 3.10%. These investments exceed the 5% threshold of the Listing Rules, thereby requiring disclosure and reporting under Chapter 14 of the Listing Rules.

For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.